MannKind Corp
MNKD
#6455
Rank
HK$5.91 B
Marketcap
HK$19.20
Share price
3.38%
Change (1 day)
-50.94%
Change (1 year)

MannKind Corp (MNKD) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : HK$4.22 Billion

According to MannKind Corp's latest financial reports the company's total liabilities are HK$4.22 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

MannKind Corp - Total liabilities on balance sheet (from 2004 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31HK$3.66 B-34.87%
2023-12-31HK$5.63 B32.11%
2022-12-31HK$4.26 B3.09%
2021-12-31HK$4.13 B84.62%
2020-12-31HK$2.24 B1.21%
2019-12-31HK$2.21 B-0.03%
2018-12-31HK$2.21 B-5.3%
2017-12-31HK$2.33 B3.75%
2016-12-31HK$2.25 B-39%
2015-12-31HK$3.69 B1.75%
2014-12-31HK$3.63 B61.85%
2013-12-31HK$2.24 B-20.03%
2012-12-31HK$2.80 B-29.61%
2011-12-31HK$3.98 B10.68%
2010-12-31HK$3.60 B51.49%
2009-12-31HK$2.37 B57.19%
2008-12-31HK$1.51 B8.16%
2007-12-31HK$1.39 B15.07%
2006-12-31HK$1.21 B632.62%
2005-12-31HK$0.16 B62.69%
2004-12-31HK$0.10 B-8.01%
2003-12-31HK$0.11 B1.52%
2002-12-31HK$0.10 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Pfizer
PFE
HK$951.35 B 22,412.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
HK$430.03 B 10,076.25%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Eli Lilly
LLY
HK$673.56 B 15,838.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$659.94 B 15,516.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
HK$19.40 B 359.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
HK$1.49 B-64.66%๐Ÿ‡บ๐Ÿ‡ธ USA